Mach-1 Financial Group »

Nurix Therapeutics shares owned by Mach-1 Financial Group

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Mach-1 Financial Group from 13F filings

Historical chart of Mach-1 Financial Group investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Mach-1 Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Mach-1 Financial Group

Quarter filed Position value Share count Share price at filing
2025-06-30 $366k 32k 11.39

More positions owned by Mach-1 Financial Group

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Global Cr Etf (DGCB)
Dimensional Etf Trust Global Core Plus (DFGP)
Dimensional Etf Trust Us High Profitab (DUHP)
Spdr Series Trust Portfolio S&p400 (SPMD)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Capital Group Growth Etf Shs Creation Uni (CGGR)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Dimensional Etf Trust Short Duration F (DFSD)
Vanguard Bd Index Fds Intermed Term (BIV)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Mach-1 Financial Group

Top funds holding Nurix Therapeutics

FMR
BlackRock
Deep Track Capital
Vanguard Group
Baker Bros. Advisors
Commodore Capital
Redmile Group
Vestal Point Capital
Point72 Asset Management
State Street Corporation
Soleus Capital Management
Kynam Capital Management
Morgan Stanley
Pictet Asset Management Holding SA
Geode Capital Management

View all funds holding Nurix Therapeutics